Evercore ISI reiterated their hold rating on shares of UiPath (NASDAQ:PATH) in a research report released on Thursday, AnalystRatings.com reports. Evercore ISI currently has a $72.00 price objective on the healthcare company’s stock.
A number of other analysts have also commented on the stock. Oppenheimer assumed coverage on shares of UiPath in a research note on Monday, May 24th. They issued a market perform rating for the company. Barclays boosted their target price on shares of UiPath from $71.00 to $73.00 and gave the company an equal weight rating in a research report on Wednesday. DA Davidson initiated coverage on shares of UiPath in a research report on Monday, May 17th. They set a buy rating and a $85.00 target price for the company. Cowen initiated coverage on shares of UiPath in a report on Monday, May 17th. They set an outperform rating and a $82.00 price target on the stock. Finally, Mizuho initiated coverage on shares of UiPath in a report on Monday, May 17th. They set a buy rating and a $77.00 price target on the stock. Eleven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus price target of $76.89.
NASDAQ:PATH opened at $74.03 on Thursday. The company’s 50-day moving average price is $56.76. UiPath has a fifty-two week low of $61.50 and a fifty-two week high of $90.00.
In related news, CEO Daniel Dines sold 1,383,168 shares of the company’s stock in a transaction on Friday, April 23rd. The shares were sold at an average price of $56.00, for a total transaction of $77,457,408.00. Also, Director Laela Sturdy sold 1,527,673 shares of the company’s stock in a transaction on Friday, April 23rd. The shares were sold at an average price of $56.00, for a total transaction of $85,549,688.00. In the last ninety days, insiders have sold 5,011,241 shares of company stock worth $280,629,496.
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. It develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities, such as robust debugging tools, application programming interface automation, wizards to automate desktop or web applications, leverage custom code, and to integrate machine learning models into production workflows.
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.